New Hypoxia probe reviewed in multicellular tumour spheroid cultures (MCTSs)

Author: Stefan Ogrodzinski

The link below connects to a new paper which reviews a novel hypoxia marker – HypoxiTRAK™ – a homogeneous live-cell permeant reagent which provides a dynamic readout of longitudinal hypoxia levels in live MCTS cultures that is compatible with HCS detection, analysis, and throughput.

Detection and impact of hypoxic regions in multicellular tumor spheroid cultures formed by head and neck squamous cell carcinoma cells lines

HypoxiTRAK™ is manufactured by BioStatus Limited – the founding company of OncoTherics.